Tower Research Capital LLC (Trc) Monopar Therapeutics Transaction History

Tower Research Capital LLC (Trc)

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.59 - $0.94 $38 - $62	66 Added 0.84%	7,922 $5,000
Q1 2024 May 15, 2024	BUY	$0.31 - $1.35 $1,313 - $5,721	4,238 Added 117.14%	7,856 $5,000
Q4 2023 Feb 13, 2024	SELL	$0.29 - $0.6 $31 - $65	-109 Reduced 2.92%	3,618 $1,000
Q3 2023 Nov 14, 2023	SELL	$0.57 - $1.0 $3 - $6	-6 Reduced 0.16%	3,727 $2,000
Q2 2023 Aug 14, 2023	BUY	$0.84 - $1.43 $2,536 - $4,318	3,020 Added 423.56%	3,733 $3,000
Q1 2023 May 09, 2023	SELL	$1.39 - $3.73 $2,944 - $7,900	-2,118 Reduced 74.81%	713 $1,000
Q4 2022 Feb 10, 2023	SELL	$2.05 - $14.95 $615 - $4,485	-300 Reduced 9.58%	2,831 $7,000
Q3 2022 Nov 10, 2022	BUY	$1.46 - $7.6 $1,108 - $5,768	759 Added 32.0%	3,131 $5,000
Q2 2022 Aug 15, 2022	SELL	$1.85 - $2.72 $2,197 - $3,231	-1,188 Reduced 33.37%	2,372 $5,000
Q1 2022 May 12, 2022	BUY	$2.5 - $3.62 $2,897 - $4,195	1,159 Added 48.27%	3,560 $9,000
Q4 2021 Feb 14, 2022	BUY	$3.17 - $5.24 $7,611 - $12,581	2,401 New	2,401 $8,000
Q2 2021 Aug 16, 2021	SELL	$5.05 - $6.49 $11,170 - $14,355	-2,212 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.76 - $10.6 $4,654 - $8,564	808 Added 57.55%	2,212 $14,000
Q4 2020 Feb 16, 2021	SELL	$4.36 - $7.49 $14,374 - $24,694	-3,297 Reduced 70.13%	1,404 $9,000
Q3 2020 Nov 16, 2020	BUY	$4.93 - $8.15 $23,175 - $38,313	4,701 New	4,701 $25,000
Q2 2020 Aug 13, 2020	SELL	$6.4 - $9.5 $435 - $646	-68 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.06 - $22.0 $344 - $1,496	68 New	68 $0

Ticker MNPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,725,800
Market Cap $316M
Description
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.